Low Colectomy Rates in Ulcerative Colitis in an Unselected European Cohort Followed for 10 Years

Gastroenterology

Volumn 132, Issue 2, 2007, Pages 507-515

  Hoie, Ole ^a   Wolters, Frank L ^b   Riis, Lene ^c   Bernklev, Tomm ^d   Aamodt, Geir ^d   Clofent, Juan ^e   Tsianos, Epaminondas ^f   Beltrami, Marina ^g   Odes, Selwyn ^h   Munkholm, Pia ^c   Vatn, Morten ^d   Stockbrügger, Reinhold W ^b   Moum, Bjorn ⁱ  

^a Section for Gastroenterology   (Norway)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF OSLO   (Norway)

^e University Hospital of Vigo   (Spain)

^f UNIVERSITY OF IOANNINA   (Greece)

^g S MARIA NUOVA HOSPITAL   (Italy)

^h BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

ⁱ AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; MERCAPTOPURINE; MESALAZINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLON RESECTION; COLON SURGERY; CONFIDENCE INTERVAL; DEATH; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSISTANT; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; ULCERATIVE COLITIS;

EID: 33847197932     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.11.015     Document Type: Article

References (28)

1. Russel M.G. Changes in the incidence of inflammatory bowel disease: what does it mean?. Eur J Intern Med 11 (2000) 191-196
2. Langholz E., Munkholm P., Davidsen M., and Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 107 (1994) 3-11
3. Bernklev T., Jahnsen J., Aadland E., Sauar J., Schulz T., Lygren I., Henriksen M., Stray N., Kjellevold O., Vatn M., and Moum B. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 39 (2004) 365-373
4. Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. Eur J Surg Suppl (1998) 90-98
5. Krause U. The surgical treatment of ulcerative colitis. Indications for surgery and results. Acta Chir Scand 144 (1978) 509-517
6. Langholz E., Munkholm P., Davidsen M., and Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103 (1992) 1444-1451
7. Leijonmarck C.E., Persson P.G., and Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 31 (1990) 329-333
8. Farmer R.G., Easley K.A., and Rankin G.B. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 38 (1993) 1137-1146
9. Stockbrugger R.W., Russel M.G., van Blankenstein M., and Shivananda S. EC-IBD: a European effort in inflammatory bowel disease. Eur J Intern Med 11 (2000) 187-190
10. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170 (1989) 2-6
11. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., and van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39 (1996) 690-697
12. Wolters F.L., van Zeijl G., Sijbrandij J., Wessels F., O'Morain C., Limonard C., Russel M.G., and Stockbrugger R.W. Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates. World J Gastroenterol 11 (2005) 7152-7158
13. Ho G.T., Drummond H., Loane J., Arnott I.D., and Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 24 (2006) 319-330
14. Albrechtsen D., Bergan A., Gjone E., Nygaard K., and Flatmark A. Elective surgery for ulcerative colitis: colectomy in 158 patients. Scand J Gastroenterol 16 (1981) 825-831
15. Frykholm G., Pahlman L., Enblad P., Krog M., and Ejerblad S. Early outcome after emergency and elective surgery for ulcerative colitis. Acta Chir Scand 155 (1989) 601-605
16. Marcello P.W., Milsom J.W., Wong S.K., Brady K., Goormastic M., and Fazio V.W. Laparoscopic restorative proctocolectomy: case-matched comparative study with open restorative proctocolectomy. Dis Colon Rectum 43 (2000) 604-608
17. Maartense S., Dunker M.S., Slors J.F., Cuesta M.A., Gouma D.J., van Deventer S.J., van Bodegraven A.A., and Bemelman W.A. Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch anal anastomosis: a randomized trial. Ann Surg 240 (2004) 984-991
18. McNevin M.S., Bax T., MacFarlane M., Moore M., Nye S., Clyde C., Lin P., Beyersdorf S., Ahmad R., and Bates D. Outcomes of a laparoscopic approach for total abdominal colectomy and proctocolectomy. Am J Surg 191 (2006) 673-676
19. Bresci G., Parisi G., Bertoni M., and Capria A. Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up. Dig Liver Dis 34 (2002) 419-423
20. Moum B., Ekbom A., Vatn M.H., Aadland E., Sauar J., Lygren I., Schulz T., Stray N., and Fausa O. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 32 (1997) 1005-1012
21. Moum B., Ekbom A., Vatn M.H., and Elgjo K. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 94 (1999) 1564-1569
22. Leidenius M., Kellokumpu I., Linden H., and Taskinen E. The true extent of ulcerative colitis? A radiological, endoscopic and histological study. APMIS 102 (1994) 950-955
23. Garcia Rodriguez L.A., Gonzalez-Perez A., Johansson S., and Wallander M.A. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 22 (2005) 309-315
24. Loftus Jr. E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
25. Boyko E.J., Perera D.R., Koepsell T.D., Keane E.M., and Inui T.S. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 23 (1988) 1147-1152
26. Beaugerie L., Massot N., Carbonnel F., Cattan S., Gendre J.P., and Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 96 (2001) 2113-2116
27. Witte J., Shivananda S., Lennard-Jones J.E., Beltrami M., Politi P., Bonanomi A., Tsianos E.V., Mouzas I., Schulz T.B., Monteiro E., Clofent J., Odes S., Limonard C.B., Stockbrugger R.W., and Russel M.G. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 35 (2000) 1272-1277
28. Lennard-Jones J.E., Shivananda S., and EC-IBD Study Group. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol 9 (1997) 353-359